Literature DB >> 9083481

Discovery of HIV-1 integrase inhibitors by pharmacophore searching.

H Hong1, N Neamati, S Wang, M C Nicklaus, A Mazumder, H Zhao, T R Burke, Y Pommier, G W Milne.   

Abstract

Based upon a class of known HIV-1 integrase inhibitors, several pharmacophore models were proposed from molecular modeling studies and validated using a 3D database of 152, compounds for which integrase assay data are known. Using the most probable pharmacophore model as the query, the NCI 3D database of 206,876 compounds was searched, and 340 compounds that contain the pharmacophore query were identified. Twenty-nine of these compounds were selected and tested in the HIV-1 integrase assay. This led to the discovery of 10 novel, structurally diverse HIV-1 integrase inhibitors, four of which have an IC50 value less than 30 microM and are promising lead compounds for further HIV-1 integrase inhibitor development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083481     DOI: 10.1021/jm960754h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

Review 1.  Computer tools in the discovery of HIV-1 integrase inhibitors.

Authors:  Chenzhong Liao; Marc C Nicklaus
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

2.  Human immunodeficiency virus type 1 cDNA integration: new aromatic hydroxylated inhibitors and studies of the inhibition mechanism.

Authors:  C M Farnet; B Wang; M Hansen; J R Lipford; L Zalkow; W E Robinson; J Siegel; F Bushman
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

3.  Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase.

Authors:  B McDougall; P J King; B W Wu; Z Hostomsky; M G Reinecke; W E Robinson
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

4.  Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design.

Authors:  Rajeshri G Karki; Yun Tang; Terrence R Burke; Marc C Nicklaus
Journal:  J Comput Aided Mol Des       Date:  2005-06-27       Impact factor: 3.686

5.  Exploring the binding of HIV-1 integrase inhibitors by comparative residue interaction analysis (CoRIA).

Authors:  Devendra K Dhaked; Jitender Verma; Anil Saran; Evans C Coutinho
Journal:  J Mol Model       Date:  2008-12-02       Impact factor: 1.810

6.  Elucidation of the molecular mechanisms of a salicylhydrazide class of compounds by proteomic analysis.

Authors:  Xuefei Cao; Carmen Plasencia; Atsuko Kanzaki; Austin Yang; Terrence R Burke; Nouri Neamati
Journal:  Curr Cancer Drug Targets       Date:  2009-03       Impact factor: 3.428

Review 7.  Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection.

Authors:  Jian J Tan; Xiao J Cong; Li M Hu; Cun X Wang; Lee Jia; Xing-Jie Liang
Journal:  Drug Discov Today       Date:  2010-01-22       Impact factor: 7.851

8.  Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts.

Authors:  Huixiao Hong; Weida Tong; Hong Fang; Leming Shi; Qian Xie; Jie Wu; Roger Perkins; John D Walker; William Branham; Daniel M Sheehan
Journal:  Environ Health Perspect       Date:  2002-01       Impact factor: 9.031

9.  Computational screening of inhibitors for HIV-1 integrase using a receptor based pharmacophore model.

Authors:  Janani Jaganatharaja; Ragul Gowthaman
Journal:  Bioinformation       Date:  2006-03-26

10.  A Rat α-Fetoprotein Binding Activity Prediction Model to Facilitate Assessment of the Endocrine Disruption Potential of Environmental Chemicals.

Authors:  Huixiao Hong; Jie Shen; Hui Wen Ng; Sugunadevi Sakkiah; Hao Ye; Weigong Ge; Ping Gong; Wenming Xiao; Weida Tong
Journal:  Int J Environ Res Public Health       Date:  2016-03-25       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.